Dimeric form of the trans-stabilized Hemolysin II C-terminal domain
DNQKALEEQM NSINSVNDKL NKGKGKLSLS MNGNQLKATS SNAGYGISYE DKNWGIFVNG EKVYTFNEKS TVGNISNDIN KLNIKGMYIE IKQI
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 38.4 % (426 of 1110) | 15.9 % (93 of 584) | 58.5 % (241 of 412) | 80.7 % (92 of 114) |
Backbone | 75.5 % (426 of 564) | 47.2 % (93 of 197) | 88.3 % (241 of 273) | 97.9 % (92 of 94) |
Sidechain | 13.2 % (83 of 631) | 0.0 % (0 of 387) | 37.1 % (83 of 224) | 0.0 % (0 of 20) |
Aromatic | 0.0 % (0 of 64) | 0.0 % (0 of 32) | 0.0 % (0 of 31) | 0.0 % (0 of 1) |
Methyl | 2.3 % (2 of 88) | 0.0 % (0 of 44) | 4.5 % (2 of 44) |
1. entity 1
DNQKALEEQM NSINSVNDKL NKGKGKLSLS MNGNQLKATS SNAGYGISYE DKNWGIFVNG EKVYTFNEKS TVGNISNDIN KLNIKGMYIE IKQISolvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303.15 K, pH 6.5, Details 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | HlyIIC | [U-99% 13C; U-99% 15N] | 0.8 mM | |
2 | sodium phosphate | natural abundance | 20 mM | |
3 | EDTA | natural abundance | 1 mM | |
4 | sodium azide | natural abundance | 0.05 % w/v | |
5 | AEBSF protease inhibitor | natural abundance | 1 mM |